Good morning, everyone, and nice to see you again after a long weekend break. Time does fly, though, and once again, we are confronting a growing to-do list filled with phone calls, things to read, and deadlines. No doubt, you can relate. So time to get cracking. Here are a few tidbits we have assembled in your honor. We hope today is productive and calm. And as always, feel free to keep in touch. We appreciate the feedback and tips. Stay safe. …
Johnson & Johnson (JNJ) paused the study of its Covid-19 vaccine due to an unexplained illness in a participant, STAT reports. A document sent to outside researchers running the 60,000-patient clinical trial states that a “pausing rule” has been met, that the online system used to enroll patients in the study has been closed, and that the data and safety monitoring board — an independent committee that watches over the safety of patients in the clinical trial — would be convened.
About the Author Reprints
